Video

Dr. Giaccone on the Challenge of Diagnosing Thymic Cancers

Giuseppe Giaconne, MD, PhD, discusses why thymic cancers can be difficult to classify histologically, so the actual incidence is unclear.

Giuseppe Giaconne, MD, PhD, is professor of medicine and associate director of clinical research at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, in New York, New York.

Cancers of the thymus, a small organ located in the mediastinum above the heart, affect 400 to 600 Americans annually. Giaconne said the disease can be difficult to classify histologically, so the actual incidence is unclear.

He added that the rareness of the disease means that few pathologists have experience detecting thymic cancer. As such, only major cancer centers have good experience classifying these maligancies.

Related Videos
Grzegorz S. Nowakowski, MD, consultant, Division of Hematology, Department of Internal Medicine, enterprise deputy director, Clinical Research, professor, oncology, medicine, Mayo Clinic Comprehensive Cancer Center
Leo I. Gordon, MD
Terence W. Friedlander, MD
Grzegorz S. Nowakowski, MD
Jill Corre, PharmD, PhD
Idoroenyi Amanam, MD
Joseph M. Scandura, MD, PhD, Weill Cornell
Rebecca Klisovic, MD, chief medical information officer, University Hospitals Seidman Cancer Center
Domenica Lorusso, MD, PhD
Nancy U. Lin, MD, associate chief, Division of Breast Oncology, Susan F. Smith Center for Women’s Cancers, director, Metastatic Breast Cancer Program, director, Program for Patients with Breast Cancer Brain Metastases, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School